Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.
Clinical trial NCT07616362 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07616362
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-04-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.